QSAR, Molecular Docking, MD Simulation and MMGBSA Calculations Approaches to Recognize Concealed Pharmacophoric Features Requisite for the Optimization of ALK Tyrosine Kinase Inhibitors as Anticancer Leads
暂无分享,去创建一个
M. Zaki | N. Jain | Aamal A. Al-Mutairi | V. Masand | R. Jawarkar | S. Al-Hussain | A. Gandhi | Abdul Samad | Arabinda Ghosh | N. Mukerjee | R. Bakal | Praveenkumar Sharma | Nobendu Mukerjee